Graphical Abstract

Keywords: homogeneous catalysis, nickel, arylation, C–H activation, azoles, pivalates, sulfonates, carbamates
1. Introduction
1.1 Significance
Transition metal-catalyzed direct arylation is an established method for the construction of biaryl bonds.1 The vast majority of currently known direct arylations use aryl halides as electrophiles.1–3 Recently, there has been an increasing interest to employ phenolic electrophiles in place of aryl halides for several reasons.4–5 First, unlike aryl halides, the phenol precursors to phenolic electrophiles can be obtained from natural sources. Second, the synthesis of phenol derivatives often requires less harsh conditions than for aryl halides. Third, several ortho-substituted phenol derivatives can be accessed via directed ortho-lithiation strategies. Finally, phenolic electrophiles might exhibit complementary reactivity to aryl halides, thereby enabling the selective functionalization of these electrophiles at different stages of complex molecule synthesis.4–5 In light of these advantages several reports on transition metal catalyzed direct arylation using C–O electrophiles have been published.4–5 Among these, nickel-catalyzed direct arylations exhibit the broadest scope of electrophiles.6–8 For example, Pd-catalyzed transformations are limited to the use of sulfonates and phosphates.9–11 In contrast, nickel-catalyzed direct arylations are known with sulfonates, carboxylates, carbamates, sulfamates and carbonates.6 This advantage of Ni-catalysis can be harnessed to its fullest potential for synthetic applications once a comprehensive understanding of the relative reactivity and scope of the various phenolic electrophiles is realized. To this end, this manuscript details the first systematic investigation of the Ni-catalyzed arylation of oxazoles with electronically and sterically diverse pivalates, tosylates, mesylates and carbamates. The following sections detail the state-of-the-art for Ni-catalyzed arylations using C–O electrophiles and present the important questions that this manuscript seeks to address.
1.2 Background
The Itami group published the first report on Ni-catalyzed C–H arylation of azoles using phenolic electrophiles in 2012.6a The reaction of benzoxazole with 2-naphthyl sulfonate, pivalate, carbonate, sulfamate and carbamate affords the desired product in excellent yields using the Ni(COD)2/dcype catalyst system (Scheme 1a). The reaction of benzoxazole was explored with electronically varied phenyl triflates (Scheme 1b). While the reaction with phenyl triflate leads to the phenylated product in good yield (75%), the yields with electron-rich and electron-deficient triflates are significantly lower (55% and 52%). The use of electronically varied, aryl pivalates, tosylates, mesylates, carbamates and carbonates is not reported.
Scheme 1.

Literature Precedent for Azole Arylation
The reaction of azoles with pivalates bearing extended π-systems affords the products in good yields (Scheme 2a). Interestingly, however, the reaction with phenyl pivalate leads to the product in only 11% yield (Scheme 2b). In 2015, one example for the coupling of benzoxazole with aryl pivalate was reported in the context of sequential Suzuki coupling/decarbonylative C–H arylation (Scheme 2c).6c The higher efficiency of C–H arylation using biphenyl pivalate (Scheme 2c) versus phenyl pivalate (Scheme 2b) may be due to the difference in the ligands employed for these reactions (dcype vs dcypt).
Scheme 2.
Literature Precedent for Azole Arylation Using Pivalates
Recently, a more general example for the arylation of imidazoles with carbamates was published.6b The reaction of N-methyl benzimidazole with electronically varied carbamates leads to products in modest to good yields (Scheme 3a). Three examples for the arylation of oxazoles were also reported with either phenyl carbamate or biphenyl carbamate to afford the products in modest yields (Scheme 3b).
Scheme 3.

Literature Precedent for Azole Arylation Using Carbamates
As part of our program on Pd- and Ni-catalyzed reactions using C–O electrophiles,12 we published the first report on the Ni-catalyzed intramolecular arylation of non-heteroaromatic C–H bonds using pivalate electrophiles (Scheme 4).12b Our results are consistent with the reports by the Itami group with respect to the electronic effect of the aryl electrophile (Scheme 1b vs. Scheme 4). The reactions of electron-rich and electron-deficient pivalate-bearing substrates afford the corresponding dibenzofuran products in lower yields than obtained with their unsubstituted counterpart. Furthermore, these reactions are most effective using pivalates. The use of carbamates, sulfonates and carbonates afford the product in lower yields.
Scheme 4.

Literature Precedent for Intramolecular C–H Arylation
1.3 Challenges and goals
The results detailed in Schemes 1–4 above are significant contributions to the field of Ni-catalyzed C–H arylations using C–O electrophiles. However, these reports also provoke several important unanswered questions that are detailed below:
The arylations presented in Schemes 1–2 are to date the only reported examples for Nicatalyzed coupling of azoles with aryl tosylates, mesylates, pivalates and carbonates. The use of electronically and sterically varied aryl tosylates and mesylates remains elusive. Furthermore, the scope of aryl pivalates for these arylations is limited primarily to the use of electrophiles bearing extended π-systems (Scheme 2a). While Scheme 2 illustrates the two published examples for the efficient use of aryl pivalates lacking extended π-systems (3-pyridyl and biphenyl pivalate), it is ambiguous whether these reaction conditions can be extended to the use of other electronically varied aryl pivalates. Hence, a systematic investigation of Ni-catalyzed arylations with respect to electronic and steric perturbations on the C–O electrophiles is necessary to delineate the scope of these transformations.
A systematic study exploring the electronic influence of the C–H substrate on the efficiency of Ni-catalyzed azole arylations using various aryl electrophiles is hitherto unknown.
A comparative study benchmarking the relative performance and scope of various C–O electrophiles for Ni-catalyzed arylations is not reported. Such investigations are necessary to understand the similarities and differences in the reaction parameters to accomplish arylations using various phenolic electrophiles.
Finally, the relative rates of Ni-catalyzed azole arylations using electrophiles bearing different leaving groups remains unknown. The knowledge of relative rates is critical to judiciously engage the various C–O electrophiles selectively at different stages in the synthesis of complex molecules.
As part of our program on transition metal catalyzed arylations using C–O electrophiles,12 this manuscript systematically addresses the aforementioned unanswered questions. Importantly, the results described herein will inform future mechanistic and synthetic investigations in the field of Ni-catalyzed C–H arylations.
2. Results and Discussion
2.1 Optimization of arylation using pivalates
Our studies commenced with the optimization of Ni-catalyzed direct arylation of 5-methyl benzoxazole (1) with para-methoxyphenyl pivalate (AOPiv). As shown in Table 1, the original reaction parameters reported by the Itami group affords product 1a, albeit in low yield (entry 1).6a The use of xylene instead of dioxane affords comparable yields of 1a (entries 1 and 2). The most significant increase in reaction efficiency was achieved using more equivalents of the pivalate electrophile leading to 1a in 83% yield (entry 4). The use of K3PO4 (vs Cs2CO3, entries 4 and 5) or higher temperatures (entries 4 and 6) afford 1a in similar yields. The use of Ni(OTf)2 as the catalyst also affords product 1a, albeit in lower yield than that obtained using Ni(COD)2 (entries 6–7).6b Interestingly, the use of dcypt6,13 instead of dcype affords 1a in excellent yields even with 1.5 equiv of the pivalate (entries 6 and 8). No product is obtained in the absence of Ni(COD)2 or the ligand (entries 9–10). These optimization results suggest that high yields of 1a can be obtained either using dcype (with 3.0 equiv of pivalate, entry 6) or dcypt (with 1.5 equiv of pivalate, entry 8). Our further investigations mainly focussed on the use of dcype conditions since this ligand is commercially available. However, dcypt was used in instances where product yields were particularly low with dcype.
Table 1.
Optimization of Arylation Using Pivalates
| ||||||
|---|---|---|---|---|---|---|
| entry | solvent | ligand | base | T(°C) | GC yield (%)a,b | |
| 1 | 1,4-dioxane | dcype | Cs2CO3 | 120 | 22 |
|
| 2 | p-xylene | dcype | Cs2CO3 | 120 | 28 | |
| 3 | p-xylene | dcype | Cs2CO3 | 140 | 40 | |
| 4c | p-xylene | dcype | Cs2CO3 | 120 | 83 | |
| 5c | p-xylene | dcype | K3PO4 | 120 | 82 | |
| 6c | p-xylene | dcype | Cs2CO3 | 140 | 89 | |
| 7c,d | p-xylene | dcype | Cs2CO3 | 140 | 73 | |
| 8 | p-xylene | dcypt | Cs2CO3 | 140 | 91 | |
| 9c | p-xylene | none | Cs2CO3 | 120 | 0 | |
| 10c,e | p-xylene | dcype | Cs2CO3 | 120 | 0 | |
General conditions: azole (1.0 equiv), pivalate (1.5 equiv), Ni(COD)2 (0.1 equiv), dcype (0.2 equiv), base (1.5 equiv), p-xylene, 120 °C.
Calibrated GC yields against hexadecane as the internal standard.
3.0 equiv of pivalate used.
General conditions but with 3.0 equiv of pivalate using Ni(OTf)2 as the catalyst.
General conditions but with 3.0 equiv of pivalate in the absence of Ni(COD)2.
2.2 Scope of pivalates for arylation of 5-methylbenzoxazole
The coupling of 5-methyl benzoxazole (1) with electronically and sterically varied pivalates was explored. As depicted in Scheme 5, electron-rich, electron-neutral, and electron-deficient pivalates participate in these reactions to afford the products in good to excellent yields. However, small variations in reaction conditions are needed for efficient reactions with electron-rich versus electron-deficient pivalates. For example, relatively electron-neutral and electron-rich pivalates perform well under the optimal conditions for the reaction of p-methoxyphenyl pivalate (Scheme 5, products 1a–1d). However, electron-deficient pivalates afford the corresponding products 1f–1g in good yields with 1.5 equivalents of the electrophile at 140 °C. Furthermore, dcypt is more effective than dcype for arylations using these electron-deficient electrophiles. Finally, ester-substituted aryl pivalates lead to products (1h and 1i) in higher yields with K3PO4 than Cs2CO3. Interestingly, sterically hindered ortho-methylphenyl pivalate affords product 1j in low yield.
Scheme 5.
Scope of Pivalates for C–H Arylationa,b
[a] General conditions: azole (1.0 equiv), pivalate (3.0 equiv), Ni(COD)2 (0.1 equiv), dcype (0.2 equiv), Cs2CO3 (1.5 equiv), p-xylene, 140 °C. [b] Isolated yields. [c] General conditions but with dcypt (0.2 equiv). [d] General conditions but with dcypt (0.2 equiv), pivalate (1.5 equiv). [e] General conditions but with pivalate (1.5 equiv) and K3PO4 (1.5 equiv). [f] General conditions but with pivalate (1.5 equiv) and K3PO4 (2.0 equiv). [g] General conditions but with dcypt (0.2 equiv), and K3PO4 (3.0 equiv).
2.3 Scope of azoles in reactions with pivalates
The reaction of pivalates with diverse azole substrates was explored next (Scheme 6). These transformations are compatible with ethers, fluorine, trifluoromethyl and benzylic alkyl groups. Benzoxazoles are generally more effective than phenyl oxazoles (cf. 2c–6c vs. 8c–10c). Analogous to 5-methylbenzoxazole reactions, the scope of phenyl oxazole arylation is also general with respect to the electronics on the pivalate electrophile (8c and 8f). Additionally, there is a noticeable electronic effect with respect to the C–H substrate for these arylations. Electron-rich and electron-neutral substrates 8 and 9 participate in these reactions to afford the products (8c and 9c) in lower yields (57% and 63%) than the electron-deficient oxazole 10 under identical reaction conditions (86% yield of 10c).14 Similarly product 4c is obtained in lower yield than 3c under the same conditions (68% versus 91% for 4c and 3c respectively). The lower yields of 8c, 9c and 4c compared to 10c and 3c, could partly be due to the diminished acidity of the azole C–H bond undergoing functionalization. The yield of 4c is enhanced (90% yield), however, using dcypt as the ligand.
Scheme 6.
Scope of Azoles for Arylation Using Pivalatesa,b
[a] General conditions: azole (1.0 equiv), pivalate (3.0 equiv), Ni(COD)2 (0.1 equiv), dcype (0.2 equiv), Cs2CO3 (1.5 equiv), p-xylene, 140 °C. [b] Isolated yields. [c] General conditions with dcypt (0.2 equiv). [d] General conditions with dcypt (0.2 equiv), and K3PO4 (3.0 equiv). [e] General conditions with dcypt (0.2 equiv), and pivalate (1.5 equiv). [f] General conditions at 120 °C.
2.4 Arylation using sulfonates
We next explored reaction conditions for coupling of azoles with tosylates and mesylates (Scheme 7). This is an advance over the previously published report,6a which primarily focused on the use of the more expensive and less bench-stable triflates (Scheme 1).
Scheme 7.
Arylation of Oxazoles Using Sulfonatesa,b
[a] General conditions: azole (1.0 equiv), sulfonate (1.5 equiv), Ni(COD)2 (0.1 equiv), dcype (0.2 equiv), Cs2CO3 (1.5 equiv), p-xylene, 120 °C. [b] Isolated yields. [c] General conditions at 100 °C. [d] General conditions with dcypt (0.2 equiv). [e] General conditions at 140 °C. [f] General conditions with sulfonate (3.0 equiv) at 140 °C. [g] General conditions with dcypt (0.2 equiv) at 140 °C. [h] General conditions with dcypt (0.2 equiv), sulfonate (3.0 equiv) at 140 °C. [i] General conditions with dcypt (0.2 equiv), and K3PO4 (3.0 equiv) at 140 °C.
The couplings of 5-methyl benzoxazole with electronically varied tosylates results in lower yields of products compared to reactions of the corresponding pivalates (Scheme 7a vs Scheme 5). Improved yields are obtained with the more atom-economical mesylates (Scheme 7b). Similar to our observation with pivalates (Scheme 5), an ortho-substituted mesylate affords the product (1j) in lower yields than para- and meta-substituted mesylates. Finally, the trends for couplings using electronically varied azoles are comparable to those observed using pivalates (Scheme 7c).
2.5 Arylation using carbamates
The scope of the arylations with carbamates is shown in Scheme 8. These reactions are more effective with K3PO4 instead of Cs2CO3.6b Under the optimal conditions the scope of these reactions are similar to that of pivalates and mesylates described above.
Scheme 8.

Arylation of Oxazoles Using Carbamatesa,b
[a] General conditions: azole (1.0 equiv), carbamate (1.5 equiv), Ni(COD)2 (0.1 equiv), dcypt (0.2 equiv), K3PO4 (3.0 equiv), p-xylene, 140 °C. [b] Isolated yields. [c] General conditions with carbamate (3.0 equiv). [d] Calibrated GC yield against hexadecane as the internal standard.
2.6 Competition studies
As mentioned in the introduction, to date Ni-catalysis exhibits the broadest scope of phenolic electrophiles (bearing different leaving groups) for direct arylations.6 This broad scope can be synthetically useful if one electrophile can be selectively engaged in direct arylations in the presence of other electrophiles. To this end, we conducted systematic competition studies to evaluate the relative reactivity of various electrophiles. The reaction of 5-methyl benzoxazole with equimolar amounts of two electronically similar electrophiles with different leaving groups was explored (Table 2). The relative amounts of products 1c and 1b obtained from these competition reactions reflect the relative rates of the reaction of the two electrophiles in the reaction vessel. For example, the reaction of equimolar amounts of PhOPiv (1.5 equiv) and p-MeC6H4OCONEt2 (1.5 equiv) with 5-methylbenzoxazole (1.0 equiv) affords 1c and 1b in 71% and 16% yields respectively (entry 1). These results (see also entry 4) suggest that the pivalate outcompetes the carbamate in these arylations, which is consistent with the better leaving group ability of pivalates. Similarly, and as expected, the mesylate undergoes arylation at a faster rate than the carbamate (entries 3 and 6). Interestingly, the vastly different leaving group abilities of mesylate versus pivalate translate into a small difference in the relative rates for the direct arylation using these electrophiles (entries 2 and 5). These results imply the following order for the relative rates of arylation: mesylate > pivalate > carbamate.
Table 2.
Competition Studies
| ||||||
|---|---|---|---|---|---|---|
| entry | X | Y | ligand | yield of 1ca (%) | yield of 1ba (%) | 1c:1b |
| 1 | OPiv | OCONEt2 | dcypt | 71 | 16 | 4.4:1 |
| 2 | OMs | OPiv | dcypt | 68 | 15 | 4.5:1 |
| 3 | OMs | OCONEt2 | dcypt | 57 | 1% | n/a |
|
| ||||||
| 4 | OCONEt2 | OPiv | dcypt | 32 | 62 | 0.52:1 |
| 5 | OPiv | OMs | dcypt | 10 | 77 | 0.13:1 |
| 6 | OCONEt2 | OMs | dcypt | 1% | 59 | n/a |
|
| ||||||
| 7 | OPiv | OCONEt2 | dcype | 67 | 25 | 2.7:1 |
| 8 | OMs | OPiv | dcype | 72 | 23 | 3.1:1 |
| 9 | OMs | OCONEt2 | dcype | 55 | 6 | 9.2:1 |
Calibrated GC yield against hexadecane as the internal standard.
Importantly, the reactivity order in these studies is the same regardless of which electrophile has phenyl or p-tolyl group (cf. entries 1–3 vs. 4–6). Overall, the results in entries 1–6 suggest that the highest difference in relative rates exists between mesylates and carbamates. Furthermore, the degree of selectivity between two leaving groups can be altered with different ligands. When competition studies were done using dcype instead of dcypt (entries 7–9), the differences in relative reaction rates decreased for all three combinations of leaving groups. The comparison between the results in entries 1–3 vs. 7–9 exemplifies the potential for further ligand optimizations to enhance the selectivity between electrophiles bearing different leaving groups.
As detailed above the highest difference in relative rates of arylation is exhibited in the competition between the mesylate and the carbamate electrophiles (Table 2, entries 3, 6 and 9). Consistent with this observation the reaction of 5-methyl benzoxazole with the electrophile bearing both the mesylate and the carbamate groups affords the product (A) resulting from the selective functionalization of the mesylate group (Scheme 9). Product B obtained via diarylation of 1 is also observed. Importantly, however, product (C) resulting from the selective functionalization of the carbamate is not observed.15 These results lend credence to the applicability of the competition studies detailed in Table 2 to the selective functionalization of leaving groups at different stages in the context of multi-step syntheses.
Scheme 9.
Intramolecular Competition Study
3. Conclusion
This manuscript details the first systematic elucidation of the electronic and steric influences of diverse azoles and phenolic electrophiles in Ni-catalyzed direct arylations. The first general report on the direct arylation of azoles with pivalates is described. The reaction of azoles with aryl tosylates, mesylates, and carbamates are also presented. Four variables critical to the optimization of these reactions are: base (Cs2CO3 or K3PO4), electrophile equivalents (1.5 or 3.0 equiv), ligands (dcype to dcypt), and temperature (100–140 °C). Establishing the general scope of these Ni-catalyzed arylations set the stage for investigating the relative rates of arylations with electrophiles bearing different leaving groups. Competition studies reveal the following order for relative rates of arylation: mesylates > pivalates > carbamates. Furthermore, these studies demonstrate the important role of ligand optimization in further enhancing the selectivity between electrophiles. Detailed mechanistic investigations to elucidate the differences in optimal reaction parameters for various combinations of azoles/electrophiles are underway and will be reported in due course. Such studies are pivotal to further broadening the scope and selectivity for these Ni-catalyzed arylations.
4. Experimental
4.1 General
NMR spectra were obtained on a Bruker 400 (399.96 MHz for 1H; 100.57 MHz for 13C) spectrometer. 1H NMR chemical shifts are reported in parts per million (ppm) relative to TMS, with the residual solvent peak used as an internal reference. Multiplicities are reported as follows: singlet (s), doublet (d), doublet of doublets (dd), triplet of doublets (td), triplet (t), quartet (q), doublet of triplets (dt), triplet of triplets (tt), multiplet (m), and broad resonance (br). IR spectra were obtained on a Thermo scientific Nicolet iS5 iD5 ATR spectrometer. Melting points were obtained on a Thomas Hoover melting point apparatus.
4.2 Materials
1,2-Bis(dicyclohexylphosphino)ethane (dcype) and 5-methylbenzoxazole were obtained from Aldrich and used as received. Benzoxazole was obtained from TCI America and used as received. Ni(COD)2 and Ni(OTf)2 were obtained from Strem chemical and used as received. Cesium carbonate, TosMic (Tosylmethylisocyanide) and K3PO4 were obtained from Acros and used as received. Benzoxazole substrates (4, 5 and 6) were prepared using literature procedures. 16 Phenyl oxazole substrates 8–10 were prepared using literature procedures.17 The pivalates, tosylates, mesylates and carbamates were prepared using literature procedures.18 2-Fluoro-4-methoxy benzaldehyde, and 2-fluoro-5-methyl benzaldehyde were obtained from Matrix Scientific and used as received. 2-Fluoro-5-(trifluoromethyl) benzaldehyde was obtained from Alfa Aesar and used as received. K2CO3 was obtained from JT Baker and used as received. 3,4-Bis-(dicyclohexylphosphino)thiophene (dcypt) was prepared using a literature procedure.19 Anhydrous p-xylene and 1,4-dioxane were obtained from Aldrich and used as received. Other solvents were obtained from Fisher Chemical or VWR Chemical and used without further purification. Flash chromatography was performed on EM Science silica gel 60 (0.040–0.063 mm particle size, 230–400 mesh) and thin layer chromatography was performed on Analtech TLC plates pre-coated with silica gel 60 F254.
4.3 Synthesis and Characterization of Substrates
4.3.1. 5-(2-fluoro-4-methoxyphenyl)-1,3-oxazole (11)
To an oven dried 20 mL scintillation vial under ambient atmosphere, was added 2-fluoro-4-methoxy benzaldehyde (617 mg, 4.00 mmol, 1.0 equiv), TosMic (929 mg, 4.76 mmol, 1.2 equiv), K2CO3 (1.82 g, 13.2 mmol, 3.3 equiv) and MeOH (8.5 mL). The vial was sealed with a Teflon lined cap and stirred at 70 °C for 2 h. Two of these same reactions were set up and combined for purification. At the end of the reaction the reaction vials were cooled to room temperature and the reaction mixture was filtered to remove the solid residues. The filtrate was concentrated and chromatographed on a silica gel column using 80/20 hexanes/EtOAc (Rf = 0.30 in 80% hexanes/20% ethyl acetate) yielded product 11 as a light yellow solid (1.27 g, 82% yield). mp = 63–64 °C. IR (neat): 1628, 1574, 1509, 1486, 1465, 1332, 1308, 1268, 1245, 1192, 1160, 1098, 1040, 1019, 951, 915, 834, 640, 629, 569 cm−1. 1H NMR (CDCl3): δ 7.90 (s, 1H), 7.66 (t, J = 8.6 Hz, 1H), 7.37 (d, J = 3.8 Hz, 1H), 6.79 (dd, J = 8.4, 2.5 Hz, 1H), 6.72 (dd, J = 12.6, 2.5 Hz, 1H), 3.84 (s, 3H). 13C NMR (CDCl3): δ 160.8 (d, J = 10.7 Hz), 159.6 (d, J = 251 Hz), 149.5, 146.0 (d, J = 3.0 Hz), 126.8 (d, J = 5.0 Hz), 123.7 (d, J = 11.6 Hz), 110.5 (d, J = 2.9 Hz), 108.9 (d, J = 13.7 Hz), 102.0 (d, J = 24.3 Hz), 55.6. HRMS Calcd for C10H8FNO2 193.0539; Found: 193.0538.
4.3.2. 5-(2-fluoro-5-methylphenyl)-1,3-oxazole (12)
To an oven dried 20 mL scintillation vial under ambient atmosphere, was added 2-fluoro-5-methyl benzaldehyde (552 mg, 4.00 mmol, 1.0 equiv), TosMic (929 mg, 4.76 mmol, 1.2 equiv), K2CO3 (1.82 g, 13.2 mmol, 3.3 equiv) and MeOH (8.5 mL). The vial was sealed with a Teflon lined cap and stirred at 70 °C for 2 h. Two of these same reactions were set up and combined for purification. At the end of the reaction the reaction vials were cooled to room temperature and the reaction mixture was filtered to remove the solid residues. The filtrate was concentrated and chromatographed on a silica gel column using 80/20 hexanes/EtOAc (Rf = 0.46 in 80% hexanes/20% ethyl acetate) yielded product 12 as a light yellow solid (1.42 g, 100% yield). mp = 73–74 °C. IR (neat): 1500, 1215, 1112, 1093, 1044, 954, 814, 757, 642 cm−1. 1H NMR (CDCl3): δ 7.94 (s, 1H), 7.56 (d, J = 7.2 Hz, 1H), 7.49 (d, J = 3.9 Hz, 1H), 7.12–7.02 (multiple peaks, 2H), 2.38 (s, 3H). 13C NMR (CDCl3): δ 157.0 (d, J = 247 Hz), 150.0, 146.0 (d, J = 3.0 Hz), 133.9 (d, J = 3.6 Hz), 130.1 (d, J = 8.0 Hz), 126.3 (d, J = 2.9 Hz), 125.5 (d, J = 12.4 Hz), 115.55 (d, J = 20.5 Hz), 115.58 (d, J = 14.5 Hz), 20.6. HRMS Calcd for C10H8FNO 177.0590; Found: 177.0587.
4.3.3. 5-[2-fluoro-5-(trifluoromethyl)phenyl]-1,3-oxazole (13)
To an oven dried 20 mL scintillation vial under ambient atmosphere, was added 2-fluoro-5-trifluoromethyl benzaldehyde (768 mg, 4.00 mmol, 1.0 equiv), TosMic (929 mg, 4.76 mmol, 1.2 equiv), K2CO3 (1.82 g, 13.2 mmol, 3.3 equiv) and MeOH (8.5 mL). The vial was sealed with a Teflon lined cap and stirred at 70 °C for 2 h. Two of these same reactions were set up and combined for purification. At the end of the reaction the reaction vials were cooled to room temperature and the reaction mixture was filtered to remove the solid residues. The filtrate was concentrated and chromatographed on a silica gel column using the Biotage flash purification system (Rf = 0.50 in 90% hexanes/10% ethyl acetate) yielded product 13 as a pale yellow solid (778 mg, 42% yield). mp = 43–44 °C. IR (neat): 1509, 1342, 1319, 1265, 1233, 1165, 1141, 1072, 1041, 949, 899, 891, 847, 826, 682, 640, 619, 585 cm−1. 1H NMR (CDCl3): δ 8.07 (dd, J = 6.5, 2.2 Hz, 1H), 8.00 (s, 1H), 7.62–7.58 (m, 1H), 7.59 (d, J = 4.1 Hz, 1H), 7.30 (t, J = 9.5 Hz, 1H). 13C NMR (CDCl3): δ 160.2 (d, J = 256 Hz), 150.7, 144.5 (d, J = 3.3 Hz), 127.5 (qd, J = 33, 3.6 Hz), 126.9 (d, J = 13.0 Hz), 126.7 (dq, J = 9.5, 3.6 Hz), 123.7 (m), 123.4 (q, J = 270 Hz), 117.0 (d, J = 14.5 Hz), 116.7 (d, J = 22.4 Hz). HRMS Calcd for C10H5F4NO 231.0307; Found: 231.0312.
4.3.4. (3-methanesulfonylphenyl) N,N-diethyl carbamate (electrophile in Scheme 9)
To an oven dried 100 mL Schlenk flask was added NaH (70.1 mg, 2.92 mmol, 1.1 equiv) and anhydrous THF (2.3 mL) in the glove box. The flask was secured with a septum, taken out of the glove box and cooled to 0 C. A solution of (3-hydroxyphenyl)methanesulfonate (500 mg, 2.66 mmol, 1.0 equiv) in THF (2.3 mL) was added dropwise to the NaH solution at 0 °C. The resulting mixture was stirred for 1 h at 0 °C. To the resulting mixture was added N,N-diethylcarbamoyl chloride dropwise at 0 °C. The reaction mixture was allowed to warm to room temperature and was stirred at room temperature overnight. The solution was then cooled to 0 °C and quenched with water. The solution was transferred to a separatory funnel, diluted with EtOAc (20 mL) and washed with NaCl (20 mL). The aqueous and organic layers were separated and the aqueous layer was extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine (20 mL), dried over MgSO4 and concentrated under vacuum. The crude product was purified using chromatography on silica gel (Rf = 0.30 in 70% hexanes/30% ethyl acetate) to yield product as a light yellow, viscous oil (492 mg, 64% yield). IR (neat): 2976, 1714, 1472, 1417, 1364, 1265, 1239, 1219, 1181, 1152, 1114, 1078, 965, 924, 878, 818, 778, 752, 709, 683 cm−1. 1H NMR (CDCl3): δ 7.42–7.37 (m, 1H), 7.15–7.12 (multiple peaks, 3H), 3.46–3.36 (multiplet, 4H), 3.15 (s, 3H), 1.27–1.19 (multiplet, 6H). 13C NMR (CDCl3): δ 153.4, 152.3, 149.3, 130.0, 120.8, 118.5, 116.0, 42.3, 41.9, 37.3, 14.2, 13.3.
4.4 C–H Arylation of Aryl Pivalates
General Procedure (A) for C–H Arylations for solid electrophiles
Ni(COD)2, ligand (dcype or dcypt), base (Cs2CO3 or K3PO4), aryl electrophile (pivalates, mesylates or carbamates) and azole were weighed into in an oven dried 20 mL scintillation vial in the glove box. Xylene was added, the vial was sealed with a Teflon lined cap, taken out of the glove box and the reaction mixture was allowed to stir at the indicated temperature for the indicated time. The reaction mixture was cooled to room temperature and filtered through a 1.0 inch plug of silica gel, eluting with Et2O (125 mL). The filtrate was concentrated and chromatographed on a silica gel column to afford the product. General Procedure (B) for C–H Arylations for solid electrophiles: Tosylate was weighed into an oven dried 20 mL scintillation vial. The vial was taken into the glove box and Ni(COD)2, ligand (dcype or dcypt), base (Cs2CO3 or K3PO4), and azole were added to it. Xylene was added, the vial was sealed with a Teflon lined cap, taken out of the glove box and the reaction mixture was allowed to stir at the indicated temperature for the indicated time. The reaction mixture was cooled to room temperature and filtered through a 1.0 inch plug of silica gel, eluting with Et2O (125 mL). The filtrate was concentrated and chromatographed on a silica gel column to afford the product.
General Procedure (C) for C–H Arylations for liquid electrophiles
Ni(COD)2, ligand (dcype or dcypt), base (Cs2CO3 or K3PO4), and azole were weighed into in an oven dried 20 mL scintillation vial in the glove box. A xylene solution of the aryl electrophile (pivalates, mesylates or carbamates) was added to the reaction mixture. The reaction vial was sealed with a Teflon lined cap, taken out of the glove box and the reaction mixture was allowed to stir at the indicated temperature for the indicated time. The reaction mixture was cooled to room temperature and filtered through a 1.0 inch plug of silica gel, eluting with Et2O (125 mL). The filtrate was concentrated and chromatographed on a silica gel column to afford the product.
General Procedure (D) for C–H Arylations for liquid electrophiles and liquid azoles
Ni(COD)2, ligand (dcype or dcypt), and base (Cs2CO3 or K3PO4) were weighed into in an oven dried 20 mL scintillation vial in the glove box. A xylene (1.0 mL) solution of the pivalate and a xylene (1.0 mL) solution of the azole was added to the reaction mixture. The reaction vial was sealed with a Teflon lined cap, taken out of the glove box and the reaction mixture was allowed to stir at the indicated temperature for the indicated time. The reaction mixture was cooled to room temperature and filtered through a 1.0 inch plug of silica gel, eluting with Et2O (125 mL). The filtrate was concentrated and chromatographed on a silica gel column to afford the product.
4.4.1 Procedures and spectral characterization of arylation products using pivalates (Scheme 5)
4.4.1.1. 2-(4-methoxyphenyl)-5-methyl-1,3-benzoxazole (1a)
Following general procedure C, 4-methoxy phenyl pivalate (312 mg, 1.50 mmol, 3.0 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.30 in 90% hexanes/10% ethyl acetate) yielded product 1a as a white solid (106 mg, 89% yield). mp = 109–110 °C. The spectroscopic data is identical to that previously reported in the literature.12c
4.4.1.2. 2-(4-methylphenyl)-5-methyl-1,3-benzoxazole (1b)
Following general procedure A, 4-methyl phenyl pivalate (288 mg, 1.50 mmol, 3.0 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.30 in 95% hexanes/5% ethyl acetate) yielded product 1b as a white solid (105 mg, 94% yield). mp = 135–136 °C. The spectroscopic data is identical to that previously reported in the literature.10c
4.4.1.3. 2-phenyl-5-methyl-1,3-benzoxazole (1c)
Following general procedure C, phenyl pivalate (134 mg, 0.75 mmol, 3.0 equiv), 5-methylbenzoxazole (33.3 mg, 0.250 mmol, 1.0 equiv), Ni(COD)2 (6.90 mg, 0.025 mmol, 0.10 equiv), dcype (21.1 mg, 0.05 mmol, 0.20 equiv), Cs2CO3 (122 mg, 0.375 mmol, 1.5 equiv), and anhydrous xylene (1.0 mL) were combined in a 4 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.39 in 95% hexanes/5% ethyl acetate) yielded product 1c as a white solid (49.0 mg, 94% yield). mp = 104–106 °C. The spectroscopic data is identical to that previously reported in the literature.20
4.4.1.4. 2-(3-methoxyphenyl)-5-methyl-1,3-benzoxazole (1d)
Following general procedure C, meta-methoxy phenyl pivalate (312 mg, 1.50 mmol, 3.0 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.34 in 90% hexanes/10% ethyl acetate) yielded product 1d as a white solid (106 mg, 89% yield). mp = 107–110 °C. The spectroscopic data is identical to that previously reported in the literature.10c
4.4.1.5. 2-(4-fluorophenyl)-5-methyl-1,3-benzoxazole (1e)
Following general procedure C, para-fluoro phenyl pivalate (294 mg, 1.50 mmol, 3.0 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 24 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.4 in 95% hexanes/5% ethyl acetate) yielded product 1e as a white solid (106 mg, 93% yield). mp = 132–134 °C. The spectroscopic data is identical to that previously reported in the literature.21
4.4.1.6. 2-[3-(trifluoromethyl)phenyl]-5-methyl-1,3-benzoxazole (1f)
Following general procedure C, meta-trifluoromethyl phenyl pivalate (185 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.42 in 95% hexanes/5% ethyl acetate) yielded product 1f as a white solid (118 mg, 85% yield). mp = 115–117 °C. The spectroscopic data is identical to that previously reported in the literature.22
4.4.1.7. 2-[4-(trifluoromethyl)phenyl]-5-methyl-1,3-benzoxazole (1g)
Following general procedure A, para-trifluoromethyl phenyl pivalate (185 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.41 in 95% hexanes/5% ethyl acetate) yielded product 1g as a white solid (70.4 mg, 51% yield). mp = 127–130 °C. The spectroscopic data is identical to that previously reported in the literature.23
4.4.1.8. ethyl 3-(5-methyl-1,3-benzoxazol-2-yl)benzoate (1h)
Following general procedure C, 3-(2,2-dimethyl-1-oxopropoxy)-ethyl ester benzoic acid (188 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.01 mmol, 0.20 equiv), K3PO4 (159 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.40 in 90% hexanes/10% ethyl acetate) yielded product 1h as a white solid (106 mg, 76% yield). mp = 97–98 °C. 1H NMR (CDCl3): δ 8.89 (t, J = 1.7 Hz, 1H), 8.43 (dt, J = 7.8, 1.5 Hz, 1H), 8.21 (dt, J = 7.8, 1.5 Hz, 1H), 7.61 (t, J = 7.8 Hz, 1H), 7.58 (s, 1H), 7.49 (d, J = 8.3 Hz, 1H), 7.19 (d, J = 8.3 Hz, 1H), 4.45 (q, J = 7.1 Hz, 2H), 2.50 (s, 3H), 1.45 (t, J = 7.1 Hz, 3H). 13C NMR (CDCl3): δ 165.7, 162.1, 149.0, 142.1, 134.5, 132.1, 131.45, 131.37, 129.0, 128.4, 127.7, 126.5, 120.0, 110.0, 61.3, 21.5, 14.3. IR (neat): 1716, 1455, 1423, 1311, 1285, 1247, 1195, 1123, 1109, 1056, 1021, 948, 921, 889, 823, 804, 765, 756, 710, 677, 614, 597 cm−1. HRMS Calcd for C17H15NO3 281.1052; Found: 281.1061.
4.4.1.9. ethyl 4-(5-methyl-1,3-benzoxazol-2-yl)benzoate (1i)
Following general procedure A, 4-(2,2-dimethyl-1-oxopropoxy)-ethyl ester benzoic acid (188 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), K3PO4 (212 mg, 1.00 mmol, 2.0 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.40 in 90% hexanes/10% ethyl acetate) yielded product 1i as a white solid (101 mg, 72% yield). mp = 153–154 °C. 1H NMR (CDCl3): δ 8.31 (d, J = 8.3 Hz, 2H), 8.19 (d, J = 8.3 Hz, 2H), 7.58 (s, 1H), 7.48 (d, J = 8.3 Hz, 1H), 7.20 (d, J = 8.4 Hz, 1H), 4.43 (q, J = 7.1 Hz, 2H), 2.50 (s, 3H), 1.43 (t, J = 7.1 Hz, 3H). 13C NMR (CDCl3): δ 165.8, 161.9, 149.0, 142.1, 134.6, 132.6, 131.0, 129.9, 127.2, 126.8, 120.1, 110.0, 61.2, 21.4, 14.2. IR (neat): 1715, 1407, 1267, 1250, 1101, 1055, 1012, 804, 777, 714 cm−1. HRMS Calcd for C17H15NO3 281.1052; Found: 281.1058.
4.4.1.10. 2-(2-methylphenyl)-5-methyl-1,3-benzoxazole (1j)
Following general procedure C, ortho-methyl phenyl pivalate (288 mg, 1.50 mmol, 3.0 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.1 mmol, 0.20 equiv), K3PO4 (318 mg, 1.50 mmol, 3.0 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 24 h. Chromatography on a silica gel column using 50/50 CH2Cl2/hexanes (Rf = 0.30 in 50% CH2Cl2/50% hexanes) yielded product 1j as a white solid (48.3 mg, 44% yield). mp = 75–77 °C. The spectroscopic data is identical to that previously reported in the literature.
4.4.2 Procedures and Spectral Characterization of Arylation products using pivalates (Scheme 6)
4.4.2.1. 2-phenyl-1,3-benzoxazole (2c)
Following general procedure D, phenyl pivalate (267 mg, 1.50 mmol, 3.0 equiv), benzoxazole (59.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.25 in 95% hexanes/5% ethyl acetate) yielded product 2c as a white solid (88.6 mg, 91% yield). mp = 101–103 °C. The spectroscopic data is identical to that previously reported in the literature.10c
4.4.2.2. 2-phenyl-5-methoxy-1,3-benzoxazole (3c)
Following general procedure C, phenyl pivalate (134 mg, 0.75 mmol, 3.0 equiv), 5-methoxybenzoxazole (37.3 mg, 0.250 mmol, 1.0 equiv), Ni(COD)2 (6.90 mg, 0.025 mmol, 0.10 equiv), dcype (21.1 mg, 0.05 mmol, 0.20 equiv), Cs2CO3 (122 mg, 0.375 mmol, 1.5 equiv), and anhydrous xylene (1.0 mL) were combined in a 4 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.42 in 90% hexanes/10% ethyl acetate) yielded product 3c as a white solid (51.4 mg, 91% yield). mp = 75–78 °C. The spectroscopic data is identical to that previously reported in the literature.24
4.4.2.3. 2-phenyl-6-methoxy-1,3-benzoxazole (4c)
Using dcype
Following general procedure C, phenyl pivalate (134 mg, 0.75 mmol, 3.0 equiv), 6-methoxybenzoxazole (37.3 mg, 0.250 mmol, 1.0 equiv), Ni(COD)2 (6.90 mg, 0.025 mmol, 0.10 equiv), dcype (21.1 mg, 0.05 mmol, 0.20 equiv), Cs2CO3 (122 mg, 0.375 mmol, 1.5 equiv), and anhydrous xylene (1.0 mL) were combined in a 4 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 18 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.34 in 90% hexanes/10% ethyl acetate) yielded product 4c as a white solid (38.2 mg, 68% yield).
Using dcypt
Following general procedure C, phenyl pivalate (267 mg, 1.50 mmol, 3.0 equiv), 6-methoxybenzoxazole (74.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 18 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.34 in 90% hexanes/10% ethyl acetate) yielded product 4c as a white solid (115 mg, 90% yield). mp = 64–67 °C. The spectroscopic data is identical to that previously reported in the literature.25
4.4.2.4. 2-phenyl-6-methyl-1,3-benzoxazole (5c)
Following general procedure C, phenyl pivalate (267 mg, 1.50 mmol, 3.0 equiv), 6-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 20 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.39 in 95% hexanes/5% ethyl acetate) yielded product 5c as a white solid (98.7 mg, 94% yield). mp = 92–94 °C. The spectroscopic data is identical to that previously reported in the literature.21
4.4.2.5. 2-phenyl-4-methyl-1,3-benzoxazole (6c)
Following general procedure D, phenyl pivalate (267 mg, 1.50 mmol, 3.0 equiv), 4-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 18 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.40 in 95% hexanes/5% ethyl acetate) yielded product 6c as a white solid (95.2 mg, 91% yield). mp = 91–93 °C. The spectroscopic data is identical to that previously reported in the literature.26
4.4.2.6. 2-phenyl-1,3-benzothiazole (7c)
Following general procedure C, phenyl pivalate (267 mg, 1.50 mmol, 3.0 equiv), benzothiazole (67.9 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), K3PO4 (318 mg, 1.50 mmol, 3.0 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 19 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.30 in 95% hexanes/5% ethyl acetate) yielded product 7c as a white solid (64.4 mg, 61% yield). mp = 112–114 °C. The spectroscopic data is identical to that previously reported in the literature.21
4.4.2.7. 2,5-diphenyl-1,3-oxazole (8c)
Following general procedure C, phenyl pivalate (214 mg, 1.20 mmol, 3.0 equiv), phenyl oxazole (58.1 mg, 0.400 mmol, 1.0 equiv), Ni(COD)2 (11.0 mg, 0.04 mmol, 0.10 equiv), dcype (33.8 mg, 0.08 mmol, 0.20 equiv), Cs2CO3 (195 mg, 0.6 mmol, 1.5 equiv), and anhydrous xylene (1.6 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 21 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.30 in 95% hexanes/5% ethyl acetate) yielded product 8c as a white solid (50.2 mg, 57% yield). mp = 72–74 °C. The spectroscopic data is identical to that previously reported in the literature.27
4.4.2.8. 5-(4-methoxyphenyl)-2-phenyl-1,3-oxazole (9c)
Following general procedure C, phenyl pivalate (134 mg, 0.75 mmol, 3.0 equiv), 5-(4-methoxyphenyl)-1,3-oxazole (43.8 mg, 0.250 mmol, 1.0 equiv), Ni(COD)2 (6.90 mg, 0.025 mmol, 0.10 equiv), dcype (21.1 mg, 0.05 mmol, 0.20 equiv), Cs2CO3 (122 mg, 0.375 mmol, 1.5 equiv), and anhydrous xylene (1.0 mL) were combined in a 4 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 21 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.29 in 95% hexanes/5% ethyl acetate) yielded product 9c as a white solid (39.4 mg, 63% yield). mp = 80–82 °C. The spectroscopic data is identical to that previously reported in the literature.28
4.4.2.9. 5-[4-(trifluoromethyl)phenyl]-2-phenyl-1,3-oxazole (10c)
Following general procedure C, phenyl pivalate (134 mg, 0.75 mmol, 3.0 equiv), 5-[4-(trifluoromethyl)phenyl]-1,3-oxazole (53.3 mg, 0.250 mmol, 1.0 equiv), Ni(COD)2 (6.90 mg, 0.025 mmol, 0.10 equiv), dcype (21.1 mg, 0.05 mmol, 0.20 equiv), Cs2CO3 (122 mg, 0.375 mmol, 1.5 equiv), and anhydrous xylene (1.0 mL) were combined in a 4 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 21 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.32 in 95% hexanes/5% ethyl acetate) yielded product 10c as a white solid (61.9 mg, 86% yield). mp = 106–108 °C. The spectroscopic data is identical to that previously reported in the literature.29
4.4.2.10. 5-phenyl-2-[3-(trifluoromethyl)phenyl]-1,3-oxazole (8f)
Following general procedure C, meta-trifluoromethylphenyl pivalate (185 mg, 0.75 mmol, 1.5 equiv), phenyloxazole (72.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.36 in 90% hexanes/10% ethyl acetate) yielded product 8f as a white solid (68.0 mg, 47% yield). mp = 127–129 °C. The spectroscopic data is identical to that previously reported in the literature.30
4.4.2.11. 5-phenyl-2-[2-methylphenyl]-1,3-oxazole (8j)
Following general procedure C, ortho-methylphenyl pivalate (230 mg, 1.20 mmol, 3.0 equiv), phenyloxazole (58.1 mg, 0.400 mmol, 1.0 equiv), Ni(COD)2 (11.0 mg, 0.04 mmol, 0.10 equiv), dcype (33.8 mg, 0.08 mmol, 0.20 equiv), Cs2CO3 (195 mg, 0.600 mmol, 1.5 equiv), and anhydrous xylene (1.6 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 120 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.30 in 95% hexanes/5% ethyl acetate) yielded product 8j as a white solid (54.0 mg, 57% yield). mp = 87–89 °C. The spectroscopic data is identical to that previously reported in the literature.10b
4.4.2.12. 5-(2-fluoro-4-methoxyphenyl)-2-phenyl-1,3-oxazole (11c)
Following general procedure C, phenyl pivalate (267 mg, 1.5 mmol, 3.0 equiv), 5-(2-fluoro-4-methoxyphenyl)-oxazole (96.7 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.75 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 20 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.27 in 90% hexanes/10% ethyl acetate) yielded product 11c as a white solid (105 mg, 78% yield). mp = 93–95 °C. 1H NMR (CDCl3): δ 8.11 (dd, J = 8.0, 1.8 Hz, 2H), 7.77 (t, J = 8.6 Hz, 1H), 7.50-7.45 (multiple peaks, 4H), 6.82 (dd, J = 8.8, 2.6 Hz, 1H), 6.75 (dd, J = 12, 2.5 Hz, 1H), 3.86 (s, 3H). 13C NMR (CDCl3): δ 159.7 (d, J = 249 Hz), 160.7 (d, J = 10.9 Hz), 160.2, 145.8 (d, J = 3.5 Hz), 130.3, 128.8, 127.3, 126.6, 126.2, 125.7 (d, J = 11.7 Hz), 110.5 (d, J = 2.9 Hz), 109.2 (d, J = 13.4 Hz), 102.1 (d, J = 24.6 Hz), 55.7. IR (neat): 1628, 1499, 1480, 1464, 1443, 1325, 1308, 1286, 1269, 1192, 1116, 1021, 961, 955, 837, 814, 779, 706, 688, 633, 618, 579 cm−1. HRMS Calcd for C16H12FNO2 269.0852; Found: 269.0842.
4.4.2.13. 5-(2-fluoro-5-methylphenyl)-2-phenyl-1,3-oxazole (12c)
Following general procedure C, phenyl pivalate (267 mg, 1.5 mmol, 3.0 equiv), 5-(2-fluoro-5-methylphenyl)-oxazole (88.8 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.75 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 20 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.30 in 95% hexanes/5% ethyl acetate) yielded product 12c as a white solid (96.2 mg, 76% yield). mp = 86–87 °C. 1H NMR (CDCl3): δ 8.15-8.13 (multiple peaks, 2H), 7.65 (d, J = 7.0 Hz, 1H), 7.57 (d, J = 3.9 Hz, 1H), 7.53-7.47 (multiple peaks, 3H), 7.12-7.04 (multiple peaks, 2H), 2.42 (s, 3H). 13C NMR (CDCl3): δ 160.7, 157.1 (d, J = 247 Hz), 145.7 (d, J = 3.6 Hz), 133.9 (d, J = 3.6 Hz), 130.4, 129.8 (d, J = 8.0 Hz), 128.7, 127.6 (d, J = 12.8 Hz), 127.2, 126.3, 126.0 (d, J = 2.9 Hz), 115.9 (d, J = 13.1 Hz), 115.6 (d, J = 20.9 Hz), 20.7. IR (neat): 1504, 1478, 1448, 1382, 1238, 1216, 1135, 1070, 1054, 967, 881, 861, 831, 814, 778, 757, 706, 691, 670, 659, 555 cm−1. HRMS Calcd for C16H12FNO 253.0903; Found: 253.0897.
4.4.2.14. 5-[2-fluoro-5-(trifluoromethyl)phenyl]-2-phenyl-1,3-oxazole (13c)
Following general procedure C, phenyl pivalate (134 mg, 0.75 mmol, 3.0 equiv), 5-(2-fluoro-5-trifluoromethylphenyl)-oxazole (57.8 mg, 0.250 mmol, 1.0 equiv), Ni(COD)2 (6.9 mg, 0.025 mmol, 0.10 equiv), dcypt (23.8 mg, 0.05 mmol, 0.20 equiv), Cs2CO3 (122 mg, 0.375 mmol, 1.5 equiv), and anhydrous xylene (1.0 mL) were combined in a 4 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 20 h. Chromatography on a silica gel column using 93/7 hexanes/EtOAc (Rf = 0.26 in 93% hexanes/7% ethyl acetate) yielded product 13c as a white solid (70.4 mg, 91% yield). mp = 143–144 °C. 1H NMR (CDCl3): δ 8.17-8.12 (multiple peaks, 3H), 7.67 (d, J = 4.0 Hz, 1H), 7.61-7.50 (multiple peaks, 4H), 7.31 (t, J = 9.5 Hz, 1H). 13C NMR (CDCl3): δ 161.6, 160.2 (d, J = 255 Hz), 144.2 (d, J = 3.1 Hz), 130.9, 129.1, 128.9, 127.5 (qd, J = 33.1, 3.5 Hz), 126.8, 126.6, 126.3 (m), 123.5 (q, J = 270 Hz), 123.3 (m), 117.4 (d, J = 14.4 Hz), 116.7 (d, J = 22.0 Hz). IR (neat): 1509, 1350, 1335, 1316, 1234, 1179, 1116, 1076, 1054, 900, 845, 780, 712, 699, 692, 682, 676, 588 cm−1. HRMS Calcd for C16H9F4NO 307.0620; Found: 307.0626.
4.4.3 Procedures and spectral characterization of arylation products using tosylates (Scheme 7a)
4.4.3.1. 2-phenyl-5-methyl-1,3-benzoxazole (1c)
Following general procedure B, phenyl tosylate (186 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 100 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.26 in 95% hexanes/5% ethyl acetate) yielded product 1c as a white solid (63.2 mg, 60% yield). The spectroscopic data is identical to that obtained using phenyl pivalate (vide supra).
4.4.3.2. 2-(4-methoxyphenyl)-5-methyl-1,3-benzoxazole (1a)
Following general procedure B, 4-methoxy phenyl tosylate (209 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 100 °C for 20 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.40 in 90% hexanes/10% ethyl acetate) yielded product 1a as a white solid (83.3 mg, 70% yield). The spectroscopic data is identical to that obtained using paramethoxyphenyl pivalate (vide supra).
4.4.3.3. 2-(3-methoxyphenyl)-5-methyl-1,3-benzoxazole (1d)
Following general procedure B, meta-methoxy phenyl tosylate (209 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 120 °C for 18 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.31 in 90% hexanes/10% ethyl acetate) yielded product 1d as a white solid (52.7 mg, 44% yield). The spectroscopic data is identical to that obtained using meta-methoxyphenyl pivalate (vide supra).
4.4.3.4. 2-[3-(trifluoromethyl)phenyl]-5-methyl-1,3-benzoxazole (1f)
Following general procedure B, meta-trifluoromethyl phenyl tosylate (237 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 120 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.42 in 95% hexanes/5% ethyl acetate) yielded product 1f as a white solid (37.3 mg, 27% yield). The spectroscopic data is identical to that obtained using meta-trifluoromethylphenyl pivalate (vide supra).
4.4.4 Procedures and spectral characterization of arylation products using mesylates (Schemes 7b and 7c)
4.4.4.1. 2-phenyl-5-methyl-1,3-benzoxazole (1c)
Following general procedure A, phenyl mesylate (129 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 120 °C for 22 h. Chromatography on a silica gel column using 96/4 hexanes/EtOAc (Rf = 0.28 in 96% hexanes/4% ethyl acetate) yielded product 1c as a white solid (86.2 mg, 82% yield). The spectroscopic data is identical to that obtained using phenyl pivalate (vide supra).
4.4.4.2. 2-(4-methylphenyl)-5-methyl-1,3-benzoxazole (1b)
Following general procedure A, 4-methyl phenyl mesylate (140 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 94/6 hexanes/EtOAc (Rf = 0.45 in 94% hexanes/6% ethyl acetate) yielded product 1b as a white solid (69.8 mg, 62% yield). The spectroscopic data is identical to that obtained using para-methylphenyl pivalate (vide supra).
4.4.4.3. 2-(4-methoxyphenyl)-5-methyl-1,3-benzoxazole (1a)
Following general procedure A, 4-methoxy phenyl mesylate (151 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 120 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.25 in 90% hexanes/10% ethyl acetate) yielded product 1a as a white solid (94.4 mg, 79% yield). The spectroscopic data is identical to that obtained using para-methoxyphenyl pivalate (vide supra).
4.4.4.4. 2-(3-methoxyphenyl)-5-methyl-1,3-benzoxazole (1d)
Following general procedure C, meta-methoxy phenyl mesylate (303 mg, 1.50 mmol, 3.0 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 18 h. Chromatography on a silica gel column using 91/9 hexanes/EtOAc (Rf = 0.31 in 91% hexanes/9% ethyl acetate) yielded product 1d as a white solid (92.1 mg, 77% yield). The spectroscopic data is identical to that obtained using meta-methoxyphenyl pivalate (vide supra).
4.4.4.5. 2-[3-(trifluoromethyl)phenyl]-5-methyl-1,3-benzoxazole (1f)
Following general procedure C, meta-trifluoromethyl phenyl mesylate (144 mg, 0.600 mmol, 1.5 equiv), 5-methylbenzoxazole (53.3 mg, 0.400 mmol, 1.0 equiv), Ni(COD)2 (11.0 mg, 0.04 mmol, 0.10 equiv), dcypt (38.1 mg, 0.08 mmol, 0.20 equiv), Cs2CO3 (195 mg, 0.600 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 21 h. Chromatography on a silica gel column using 94/6 hexanes/EtOAc (Rf = 0.29 in 94% hexanes/6% ethyl acetate) yielded product 1f as a white solid (62.5 mg, 56% yield). The spectroscopic data is identical to that obtained using meta-trifluoromethylphenyl pivalate (vide supra).
4.4.4.6. 2-(2-methylphenyl)-5-methyl-1,3-benzoxazole (1j)
Following general procedure C, ortho-methyl phenyl mesylate (279 mg, 1.50 mmol, 3.0 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcype (42.3 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 97/3 hexanes/EtOAc (Rf = 0.34 in 97% hexanes/3% ethyl acetate) yielded product 1j as a white solid (32.9 mg, 30% yield). The spectroscopic data is identical to that previously reported in the literature.27
4.4.4.7. 2,5-diphenyl-1,3-oxazole (8c)
Following general procedure A, phenyl mesylate (258 mg, 1.50 mmol, 3.0 equiv), phenyl oxazole (72.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.75 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.40 in 95% hexanes/5% ethyl acetate) yielded product 8c as a white solid (63.7 mg, 58% yield). The spectroscopic data is identical to that obtained using phenyl pivalate (vide supra).
4.4.4.8. 5-(4-methoxyphenyl)-2-phenyl-1,3-oxazole (9c)
Using dcypt and Cs2CO3
Following general procedure A, phenyl mesylate (258 mg, 1.50 mmol, 3.0 equiv), 5-(4-methoxyphenyl)-1,3-oxazole (87.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.40 in 90% hexanes/10% ethyl acetate) yielded product 9c as a white solid (44.6 mg, 35% yield). The spectroscopic data is identical to that obtained using phenyl pivalate (vide supra).
Using dcypt and K3PO4
Following general procedure A in a 4 mL scintillation vial, phenyl mesylate (64.6 mg, 0.375 mmol, 1.5 equiv), 5-(4-methoxyphenyl)-1,3-oxazole (43.8 mg, 0.250 mmol, 1.0 equiv), Ni(COD)2 (6.9 mg, 0.025 mmol, 0.10 equiv), dcypt (23.8 mg, 0.05 mmol, 0.20 equiv), K3PO4 (159 mg, 0.750 mmol, 3.0 equiv), and anhydrous xylene (1.0 mL) were combined. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.40 in 90% hexanes/10% ethyl acetate) yielded product 9c as a white solid (32.1 mg, 52% yield). The spectroscopic data is identical to that obtained using phenyl pivalate (vide supra).
4.4.4.9. 5-[4-(trifluoromethyl)phenyl]-2-phenyl-1,3-oxazole (10c)
Following general procedure A, phenyl mesylate (258 mg, 1.50 mmol, 3.0 equiv), 5-[4-(trifluoromethyl)phenyl]-1,3-oxazole (107 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), Cs2CO3 (244 mg, 0.750 mmol, 1.5 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.32 in 95% hexanes/5% ethyl acetate) yielded product 10c as a white solid (111 mg, 77% yield). The spectroscopic data is identical to that obtained using phenyl pivalate (vide supra).
4.4.5 Procedures and spectral characterization of arylation products using carbamates (Scheme 8)
4.4.5.1. 2-phenyl-5-methyl-1,3-benzoxazole (1c)
Following general procedure C, N,N-diethyl-phenyl carbamate (145 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), K3PO4 (318 mg, 1.50 mmol, 3.0 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 23 h. Chromatography on a silica gel column using 94/6 hexanes/EtOAc (Rf = 0.45 in 94% hexanes/6% ethyl acetate) yielded product 1c as a white solid (86.4 mg, 83% yield). The spectroscopic data is identical to that obtained using phenyl pivalate (vide supra).
4.4.5.2. 2-(4-methylphenyl)-5-methyl-1,3-benzoxazole (1b)
Following general procedure C, N,N-diethyl-4-methyl phenyl carbamate (152 mg, 0.733 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), K3PO4 (318 mg, 1.50 mmol, 3.0 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.30 in 95% hexanes/5% ethyl acetate) yielded product 1b as a white solid (87.9 mg, 79% yield). The spectroscopic data is identical to that obtained using para-methylphenyl pivalate (vide supra).
4.4.5.3. 2-(4-methoxyphenyl)-5-methyl-1,3-benzoxazole (1a)
Following general procedure C, N,N-diethyl-4-methoxy phenyl carbamate (167 mg, 0.750 mmol, 3.0 equiv), 5-methylbenzoxazole (33.3 mg, 0.250 mmol, 1.0 equiv), Ni(COD)2 (6.9 mg, 0.025 mmol, 0.10 equiv), dcypt (23.8 mg, 0.05 mmol, 0.20 equiv), K3PO4 (159 mg, 0.75 mmol, 3.0 equiv), and anhydrous xylene (1.0 mL) were combined in a 4 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 20 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.28 in 90% hexanes/10% ethyl acetate) yielded product 1a as a white solid (40.3 mg, 67% yield). The spectroscopic data is identical to that obtained using para-methoxyphenyl pivalate (vide supra).
4.4.5.4. 2-(3-methoxyphenyl)-5-methyl-1,3-benzoxazole (1d)
Following general procedure C, N,N-diethyl-meta-methoxyphenyl carbamate (83.7 mg, 0.375 mmol, 1.5 equiv), 5-methylbenzoxazole (33.3 mg, 0.250 mmol, 1.0 equiv), Ni(COD)2 (6.9 mg, 0.025 mmol, 0.10 equiv), dcypt (23.8 mg, 0.05 mmol, 0.20 equiv), K3PO4 (159 mg, 0.750 mmol, 3.0 equiv), and anhydrous xylene (1.0 mL) were combined in a 4 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.34 in 90% hexanes/10% ethyl acetate) yielded product 1d as a white solid (49.6 mg, 83% yield). The spectroscopic data is identical to that obtained using meta-methoxyphenyl pivalate (vide supra).
4.4.5.5. 2-[3-(trifluoromethyl)phenyl]-5-methyl-1,3-benzoxazole (1f)
Following general procedure C, N,N-diethyl-meta-trifluoromethylphenyl carbamate (195 mg, 0.750 mmol, 1.5 equiv), 5-methylbenzoxazole (66.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), K3PO4 (318 mg, 1.50 mmol, 3.0 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.41 in 95% hexanes/5% ethyl acetate) yielded product 1f as a white solid (91.0 mg, 66% yield). The spectroscopic data is identical to that obtained using meta-trifluoromethylphenyl pivalate (vide supra).
4.4.5.6. 2-(2-methylphenyl)-5-methyl-1,3-benzoxazole (1j)
Following general procedure C, ortho-methyl phenyl carbamate (60.7 mg, 0.293 mmol, 3.0 equiv), 5-methylbenzoxazole (13.3 mg, 0.100 mmol, 1.0 equiv), Ni(COD)2 (2.80 mg, 0.01 mmol, 0.10 equiv), dcypt (9.50 mg, 0.02 mmol, 0.20 equiv), K3PO4 (63.7 mg, 0.300 mmol, 3.0 equiv), and anhydrous xylene (0.4 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. The reaction mixture was cooled to room temperature and diluted with EtOAc. Hexadecane (0.100 mmol) was added and an aliquot of this reaction mixture was analyzed using GC/MS, which showed 22% yield of product 1j.
4.4.5.7. 2,5-diphenyl-1,3-oxazole (8c)
Following general procedure C, N,N-diethyl-phenyl carbamate (145 mg, 0.75 mmol, 1.5 equiv), phenyl oxazole (72.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), K3PO4 (318 mg, 1.50 mmol, 3.0 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 95/5 hexanes/EtOAc (Rf = 0.30 in 95% hexanes/5% ethyl acetate) yielded product 8c as a white solid (71.1 mg, 64% yield). The spectroscopic data is identical to that obtained using phenyl pivalate (vide supra).
4.4.5.8. 5-(4-methoxyphenyl)-2-phenyl-1,3-oxazole (9c)
Following general procedure C, N,N-diethyl-phenyl carbamate (145 mg, 0.75 mmol, 1.5 equiv), 5-(4-methoxyphenyl)-1,3-oxazole (87.6 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), K3PO4 (318 mg, 1.50 mmol, 3.0 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22 h. Chromatography on a silica gel column using 90/10 hexanes/EtOAc (Rf = 0.40 in 90% hexanes/10% ethyl acetate) yielded product 9c as a white solid (44.8 mg, 36% yield). The spectroscopic data is identical to that obtained using phenyl pivalate (vide supra).
4.4.5.9. 5-[4-(trifluoromethyl)phenyl]-2-phenyl-1,3-oxazole (10c)
Following general procedure C, N,N-diethyl-phenyl carbamate (145 mg, 0.75 mmol, 1.5 equiv), 5-[4-(trifluoromethyl)phenyl]-1,3-oxazole (107 mg, 0.500 mmol, 1.0 equiv), Ni(COD)2 (13.8 mg, 0.05 mmol, 0.10 equiv), dcypt (47.7 mg, 0.10 mmol, 0.20 equiv), K3PO4 (318 mg, 1.50 mmol, 3.0 equiv), and anhydrous xylene (2.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 22.5 h. Chromatography on a silica gel column using 94/6 hexanes/EtOAc (Rf = 0.27 in 94% hexanes/6% ethyl acetate) yielded product 10c as a white solid (74.1 mg, 51% yield). The spectroscopic data is identical to that obtained using phenyl pivalate (vide supra).
4.4.6 Procedures for competition studies (Table 2 and Scheme 9)
4.4.6.1
Procedures for competition studies with two liquid electrophiles (Table 2, entries 1 and 7): Ni(COD)2 (2.80 mg, 0.01 mmol, 0.1 equiv), ligand (dcype or dcypt) (8.6 or 9.5 mg, 0.02 mmol, 0.2 equiv), Cs2CO3 (48.9 mg, 0.15 mmol, 1.5 equiv), and 5-methylbenzoxazole (13.3 mg, 0.100 mmol, 1.0 equiv) were weighed into in an oven dried 4 mL scintillation vial in the glove box. A xylene solution (0.2 mL) of the phenyl electrophile (0.15 mmol, 1.5 equiv) and a xylene solution (0.2 mL) of p-MeC6H4 electrophile (0.15 mmol, 1.5 equiv) were added to the reaction mixture. The reaction vial was sealed with a Teflon lined cap, taken out of the glove box and the reaction mixture was allowed to stir at 140 °C for 22 h. The reaction mixture was cooled to room temperature, diluted with EtOAc (1 mL) and filtered through silica gel, eluting with EtOAc (2 mL). Hexadecane (0.029 mL, 1.0 equiv) was added to the reaction mixture. An aliquot of the reaction mixture was analyzed using GC/MS and the calibrated GC yield of the product against the hexadecane standard was calculated.
4.4.6.2
Procedures for competition studies with two solid electrophiles (Table 2, entries 2 and 8): Ni(COD)2 (2.80 mg, 0.01 mmol, 0.1 equiv), ligand (dcype or dcypt) (8.6 or 9.5 mg, 0.02 mmol, 0.2 equiv), Cs2CO3 (48.9 mg, 0.15 mmol, 1.5 equiv), 5-methylbenzoxazole (13.3 mg, 0.100 mmol, 1.0 equiv), phenyl electrophile (0.15 mmol, 1.5 equiv), p-MeC6H4 electrophile (0.15 mmol, 1.5 equiv) and xylene (0.4 mL) were added to an oven dried 4 mL scintillation vial. The reaction vial was sealed with a Teflon lined cap, taken out of the glove box and the reaction mixture was allowed to stir at 140 °C for 22 h. The reaction mixture was cooled to room temperature, diluted with EtOAc (1 mL) and filtered through silica gel, eluting with EtOAc (2 mL). Hexadecane (0.029 mL, 1.0 equiv) was added to the reaction mixture. An aliquot of the reaction mixture was analyzed using GC/MS and the calibrated GC yield of the product against the hexadecane standard was calculated.
4.4.6.3
Procedures for competition studies with solid phenyl electrophile and liquid p-Mephenyl electrophile (Table 2, entries 3 and 9): Ni(COD)2 (2.80 mg, 0.01 mmol, 0.1 equiv), ligand (dcype or dcypt) (8.6 or 9.5 mg, 0.02 mmol, 0.2 equiv), Cs2CO3 (48.9 mg, 0.15 mmol, 1.5 equiv), 5-methylbenzoxazole (13.3 mg, 0.100 mmol, 1.0 equiv), and phenyl electrophile (0.15 mmol, 1.5 equiv) were added to an oven dried 4 mL scintillation vial. A xylene (0.4 mL) solution of p- MeC6H4 electrophile (0.15 mmol, 1.5 equiv) was added to the reaction vial. The reaction vial was sealed with a Teflon lined cap, taken out of the glove box and the reaction mixture was allowed to stir at 140 °C for 22 h. The reaction mixture was cooled to room temperature, diluted with EtOAc (1 mL) and filtered through silica gel, eluting with EtOAc (2 mL). Hexadecane (0.029 mL, 1.0 equiv) was added to the reaction mixture. An aliquot of the reaction mixture was analyzed using GC/MS and the calibrated GC yield of the product against the hexadecane standard was calculated.
4.4.6.4
Procedures for competition studies with liquid phenyl electrophile and solid p-Mephenyl electrophile (Table 3, entries 4–6): Ni(COD)2 (2.80 mg, 0.01 mmol, 0.1 equiv), ligand (dcype or dcypt) (8.6 or 9.5 mg, 0.02 mmol, 0.2 equiv), Cs2CO3 (48.9 mg, 0.15 mmol, 1.5 equiv), 5-methylbenzoxazole (13.3 mg, 0.100 mmol, 1.0 equiv), and p-MeC6H4 electrophile (0.15 mmol, 1.5 equiv) were added to an oven dried 4 mL scintillation vial. A xylene (0.4 mL) solution of the phenyl electrophile (0.15 mmol, 1.5 equiv) was added to the reaction vial. The reaction vial was sealed with a Teflon lined cap, taken out of the glove box and the reaction mixture was allowed to stir at 140 °C for 22 h. The reaction mixture was cooled to room temperature, diluted with EtOAc (1 mL) and filtered through silica gel, eluting with EtOAc (2 mL). Hexadecane (0.029 mL, 1.0 equiv) was added to the reaction mixture. An aliquot of the reaction mixture was analyzed using GC/MS and the calibrated GC yield of the product against the hexadecane standard was calculated.
4.4.6.5. 2-[3-N,N-diethylcarbamoyl phenyl]-5-methyl-1,3-benzoxazole (product A in Scheme 9)
Following general procedure C, (3-methanesulfonylphenyl) N,N-diethyl carbamate (215 mg, 0.75 mmol, 3.0 equiv), 5-methyl benzoxazole (33.3 mg, 0.250 mmol, 1.0 equiv), Ni(COD)2 (6.9 mg, 0.025 mmol, 0.10 equiv), dcypt (23.8 mg, 0.05 mmol, 0.20 equiv), Cs2CO3 (122 mg, 0.37 mmol, 1.5 equiv), and anhydrous xylene (1.0 mL) were combined in a 20 mL scintillation vial. The reaction mixture was allowed to stir at 140 °C for 24 h. Chromatography on a silica gel column using 95/5 to 93/7 EtOAc/hexanes (Rf = 0.13 in 93% hexanes/7% ethyl acetate) yielded product (25 mg, 30% yield). 1H NMR (CDCl3): δ 8.07 (dt, J = 7.8, 1.4 Hz, 1H), 8.00 (t, J = 1.9 Hz, 1H), 7.55 (s, 1H), 7.50 (t, J = 8.0 Hz, 1H), 7.44 (d, J = 8.3 Hz, 1H), 7.33-7.31 (m, 1H), 7.16 (dd, J = 8.3, 1.7 Hz, 1H), 3.50-3.39 (m, 4H), 2.49 (s, 3H), 1.31-1.21 (m, 6H).
Supplementary Material
Acknowledgments
This work was supported by the NIH NIGMS (R15 GM107892), NSFCAREER Award (CHE-1554630) and St Olaf College. The authors are grateful to Mckenna Hanson (undergraduate student) for the synthesis of a few oxazole substrates.
Footnotes
Supplementary Data. Supplementary data containing 1H NMR spectra (for new substrates and all catalysis products) and 13C NMR spectra (for all new compounds) can be found.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References and notes
- 1.For representative reviews on transition metal-catalyzed C–H arylation see: Alberico D, Scott ME, Lautens M. Chem Rev. 2007;107:174–238. doi: 10.1021/cr0509760.Kakiuchi F, Kochi T. Synthesis. 2008:3013–3039.McGlacken GP, Bateman LM. Chem Soc Rev. 2009;38:2447–2464. doi: 10.1039/b805701j.Ackermann L, Vicente R, Kapdi AR. Angew Chem Int Ed. 2009;48:9792–9826. doi: 10.1002/anie.200902996.Chiusoli GP, Catellani M, Costa M, Motti E, Della Ca’ N, Maestri G. Coord Chem Rev. 2010;254:456–469.Kuhl N, Hopkinson MN, Wencel-Delord J, Glorius F. Angew Chem, Int Ed. 2012;51:10236–10254. doi: 10.1002/anie.201203269.Rousseaux S, Liegault B, Fagnou K. In: Modern Tools for Synthesis of Complex Bioactive Molecules. Cossy J, Arseniyadis S, editors. Wiley-VCH; 2012. pp. 1–32.Rossi R, Bellina F, Lessi M, Manzini C. Adv Synth & Catal. 2014;356:17–117.Segawa Y, Maekawa T, Itami K. Angew Chem Int Ed. 2015;54:66–81. doi: 10.1002/anie.201403729.
- 2.For representative reviews on Pd-catalyzed C–H arylation see: Chen X, Engle KM, Wang DH, Yu JQ. Angew Chem, Int Ed. 2009;48:5094–5115. doi: 10.1002/anie.200806273.Lyons TW, Sanford MS. Chem Rev. 2010;110:1147–1169. doi: 10.1021/cr900184e.Daugulis O. Top Curr Chem. 2010;292:57–84. doi: 10.1007/128_2009_10.Gorelsky S, Lapointe D, Fagnou K. J Org Chem. 2012;77:658–668. doi: 10.1021/jo202342q.
- 3.For representative reviews on Ni-catalyzed arylation see: Yamaguchi J, Muto K, Itami K. Eur J Org Chem. 2013:19–30.Tasker SZ, Standley EA, Jamison TF. Nature. 2014;509:299–309. doi: 10.1038/nature13274.Cai X, Xie B. Arkivoc. 2015:184–211.Khan MS, Haque A, Al-Suti MK, Raithby PR. J Organomet Chem. 2015;793:114–133.Johnson SA. Dalton Trans. 2015;44:10905–10913. doi: 10.1039/c5dt00032g.Ananikov VP. ACS Catal. 2015;5:1964–1971.Hyster TK. Catal Lett. 2015;145:458–467.
- 4.a) Antoft-Finch A, Blackburn T, Snieckus V. J Am Chem Soc. 2009;131:17750–17752. doi: 10.1021/ja907700e. [DOI] [PubMed] [Google Scholar]; b) Yu D-G, Li B-J, Shi Z-J. Acc Chem Res. 2010;43:1486–1495. doi: 10.1021/ar100082d. [DOI] [PubMed] [Google Scholar]; c) Rosen BM, Quasdorf KW, Wilson DA, Zhang N, Resmerita AM, Garg NK, Percec V. Chem Rev. 2011;111:1346–1416. doi: 10.1021/cr100259t. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Li BJ, Yu D-G, Sun C-L, Shi Z-J. Chem Eur J. 2011;17:1728–1759. doi: 10.1002/chem.201002273. [DOI] [PubMed] [Google Scholar]; e) Tobisu M, Chatani N. Top Organomet Chem. 2013;44:37–54. [Google Scholar]; f) Tobisu M, Chatani N. Acc Chem Res. 2015;48:1717–1726. doi: 10.1021/acs.accounts.5b00051. [DOI] [PubMed] [Google Scholar]; g) Mesganaw T, Garg NK. Org Process Res Dev. 2013;17:29–39. [Google Scholar]
- 5.a) So CM, Kwong FY. Chem Soc Rev. 2011;40:4963–4972. doi: 10.1039/c1cs15114b. [DOI] [PubMed] [Google Scholar]; b) Kozhushkov SI, Potukuchi HK, Ackermann L. Catal Sci Technol. 2013;3:562–571. [Google Scholar]
- 6.For Ni-catalyzed C–H arylation using C–O electrophiles see: Muto K, Yamaguchi J, Itami K. J Am Chem Soc. 2012;134:169–172. doi: 10.1021/ja210249h.Muto K, Hatakeyama T, Yamaguchi J, Itami K. Chem Sci. 2015;6:6792–67. doi: 10.1039/c5sc02942b.Muto K, Yamaguchi J, Musaev DG, Itami K. Nature Commun. 2015;6:1–8. doi: 10.1038/ncomms8508.Wang Y, Wu S-B, Shi W-J, Shi Z-J. Org Lett. 2016;18:2548–2551. doi: 10.1021/acs.orglett.6b00819.
- 7.For Ni-catalyzed C–H allylation, alkenylation and benzylation using C–O electrophiles see: Meng L, Kamada Y, Muto K, Yamaguchi J, Itami K. Angew Chem Int Ed. 2013;52:10048–10051. doi: 10.1002/anie.201304492.Cong X, Li Y, Wei Y, Zeng X. Org Lett. 2014;16:3926–3929. doi: 10.1021/ol501707z.Xiao J, Chen T, Han L-B. Org Lett. 2015;17:812–815. doi: 10.1021/ol503607h.
- 8.For Mechanistic Studies on Ni-catalyzed C–H arylation using C–O electrophiles see: Muto K, Yamaguchi J, Lei A, Itami K. J Am Chem Soc. 2013;135:16384–16387. doi: 10.1021/ja409803x.Xu H, Muto K, Yamaguchi J, Zhao C, Itami K, Musaev DG. J Am Chem Soc. 2014;136:14834–14844. doi: 10.1021/ja5071174.Lu Q, Yu H, Fu Y. J Am Chem Soc. 2014;136:8252–8260. doi: 10.1021/ja4127455.Li Z, Liu L. Chin J Catal. 2015;36:3–14.
- 9.For some representative reports on Pd-catalyzed direct arylation using triflates see: Cruz ACF, Miller ND, Willis MC. Org Lett. 2007;9:4391–4393. doi: 10.1021/ol702044z.Roger J, Doucet H. Org Biomol Chem. 2008;6:169–174. doi: 10.1039/b715235c.Schipper DJ, El-Salfiti M, Whipp CJ, Fagnou K. Tetrahedron. 2009;65:4977–4983.Jiao J, Murakami K, Itami K. Chem Lett. 2016;45:529–531.
- 10.For representative reports on Pd-catalyzed direct arylation using tosylates see: Ackermann L, Althammer A, Born R. Angew Chem Int Ed. 2006;45:2619–2622. doi: 10.1002/anie.200504450.Ackermann L, Althammer A, Fenner S. Angew Chem Int Ed. 2009;48:201–204. doi: 10.1002/anie.200804517.Ackermann L, Barfüsser S, Pospech J. Org Lett. 2010;12:724–726. doi: 10.1021/ol9028034.Ackermann L, Fenner S. Chem Commun. 2011;47:430–432. doi: 10.1039/c0cc02360d.Fan S, Yang J, Zhang X. Org Lett. 2011;13:4374–4377. doi: 10.1021/ol201706t.
- 11.For representative reports on Pd-catalyzed direct arylation using mesylates see: So CM, Lau CP, Kwong FY. Chem Eur J. 2011;17:761–765. doi: 10.1002/chem.201002354.Chang JWW, Chia EY, Chai CLL, Seayad J. Org Biomol Chem. 2012;10:2289–2299. doi: 10.1039/c2ob06840k.Lee DS, Choy PY, So CM, Wang J, Lau CP, Kwong FY. RSC Adv. 2012;2:9179–9182.
- 12.a) Nervig CS, Waller PJ, Kalyani D. Org Lett. 2012;14:4838–4841. doi: 10.1021/ol302166n. [DOI] [PubMed] [Google Scholar]; b) Wang J, Ferguson D, Kalyani D. Tetrahedron. 2013;69:5780–5790. [Google Scholar]; c) Ferguson D, Rudolph SR, Kalyani D. ACS Catal. 2014;4:2395–2401. doi: 10.1021/cs500587b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.For previous uses of dcypt ligand in Ni-catalyzed cross-couplings see: Takise R, Muto K, Yamaguchi J, Itami K. Angew Chem Int Ed. 2014;53:6791–6794. doi: 10.1002/anie.201403823.Koch E, Takise R, Studer A, Yamaguchi J, Itami K. Chem Commun. 2015;51:855–857. doi: 10.1039/c4cc08426h.
- 14.For similar electronic effects for Ni-catalyzed arylation of benzimidazoles using carbamates see ref. 6b.
- 15.Phenyl carbamate (presumably formed via proto-demesylation of the electrophile) was also isolated. Product 1c resulting from the coupling of the azole with the phenyl carbamate (formed under the reaction conditions) was observed (~7%). The yields are approximate because the NMR’s for products A, B and 1c contain trace impurities. The NMR for product B is contaminated with phenyl carbamate. The supporting information contains the proton NMR spectra for the products isolated from the experiment detailed in Scheme 9.
- 16.Lee J, Kim J, Jun Y, Lee B, Kim B. Tetrahedron Lett. 2009;65:8821–8831. [Google Scholar]
- 17.Zhao X, Ding F, Li J, Lu K, Lu X, Wang B, Yu P. Tetrahedron Lett. 2015;56:511–513. [Google Scholar]
- 18.(a) Quasdorf K, Tian X, Garg N. J Am Chem Soc. 2008;130:14422–14423. doi: 10.1021/ja806244b. [DOI] [PubMed] [Google Scholar]; (b) Lei X, Jalla A, Shama MAA, Stafford J, Cao B. Synthesis. 2015;47:2578–2585. [Google Scholar]
- 19.Takise R, Muto K, Yamaguchi J, Itami K. Angew Chem Int Ed. 2014;53:6791– 6794. doi: 10.1002/anie.201403823. [DOI] [PubMed] [Google Scholar]
- 20.Aksenov NA, Aksenov AV, Nadein ON, Aksenov DA, Smirnov AN, Rubin M. RSC Adv. 2015;5:71620–71626. [Google Scholar]
- 21.Yang D, Liu P, Zhang N, Wei W, Yue M, You J, Wang H. Chem Cat Chem. 2014;6:3434–3439. [Google Scholar]
- 22.Wang L, Ren X, Yu J, Jiang Y, Cheng J. J Org Chem. 2013;78:12076–12081. doi: 10.1021/jo402106q. [DOI] [PubMed] [Google Scholar]
- 23.Zhang M, Zhang S, Liu M, Cheng J. Chem Commun. 2011;47:11522–11524. doi: 10.1039/c1cc14718h. [DOI] [PubMed] [Google Scholar]
- 24.Tang L, Guo X, Yang Y, Zha Z, Wang Z. Chem Commun. 2014;50:6145–6148. doi: 10.1039/c4cc01822b. [DOI] [PubMed] [Google Scholar]
- 25.Marsden S, McGonagle A, McKeever-Abbas B. Org Lett. 2008;10:2589–2591. doi: 10.1021/ol800921n. [DOI] [PubMed] [Google Scholar]
- 26.Bochatay VN, Boissarie PJ, Murphy JA, Suckling CJ, Lang S. J Org Chem. 2013;78:1471–1477. doi: 10.1021/jo302544d. [DOI] [PubMed] [Google Scholar]
- 27.Shen X, Zhang Y, Chen W, Xiao Z, Hu T, Shao L. Org Lett. 2014;16:1984–1987. doi: 10.1021/ol500531m. [DOI] [PubMed] [Google Scholar]
- 28.Williams D, Fu L. Org Lett. 2010;12:808–811. doi: 10.1021/ol902833p. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Ohnmacht S, Mamone P, Culshaw A, Greaney M. Chem Commun. 2008:1241–1243. doi: 10.1039/b719466h. [DOI] [PubMed] [Google Scholar]
- 30.Besselièvre F, Mahuteau-Betzer F, Grierson D, Piguel S. J Org Chem. 2008;73:3278–3280. doi: 10.1021/jo7027135. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





